A recent analysis highlights a significant global health concern, revealing that over three-quarters of the world’s population is not consuming adequate levels of omega-3 fatty acids. This deficiency poses an increased risk for heart disease, cognitive decline, inflammation, and vision problems. The findings, published in the journal Nutrition Research Reviews, were conducted by researchers from the University of East Anglia, the University of Southampton, and Holland & Barrett.
The review indicates that approximately 76% of people worldwide fail to meet the recommended daily intake of essential omega-3 fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). According to global health guidelines, most adults should aim for at least 250 milligrams of EPA and DHA combined each day. Unfortunately, actual consumption levels are significantly lower in many regions, increasing potential health risks.
To understand the implications of this deficiency, Fox News Digital consulted Michelle Routhenstein, a preventive cardiology dietitian based in New York at Entirely Nourished. Routhenstein confirmed that low omega-3 levels can adversely affect heart health, cognitive function, and overall inflammation in the body. She noted that insufficient intake is associated with an elevated risk of heart attacks and sudden cardiac death, along with higher triglyceride levels, irregular heart rhythms, and arterial plaque buildup.
Research has also linked inadequate omega-3 levels to declines in brain function. This includes a heightened risk of Alzheimer’s disease and increased rates of depression. Routhenstein emphasized that low omega-3 levels may exacerbate inflammation in autoimmune conditions like psoriasis and negatively impact eye health due to omega-3s’ crucial role in retinal structure.
To improve omega-3 intake, Routhenstein advised individuals to recognize their dietary needs and sources. The richest natural sources of EPA and DHA are oily fish such as salmon, mackerel, sardines, herring, trout, and anchovies. She recommended consuming oily fish three to four times a week for optimal health benefits. For those who do not regularly eat fish, omega-3 supplements can help elevate EPA and DHA levels.
When considering omega-3 supplementation, Routhenstein stated that dosages should be tailored to individual health needs, including lab results and medical history. Moderate, quality-controlled supplements are generally safe for most individuals. Prescription-strength omega-3 products have shown promise as well. For instance, high doses of EPA, such as 4 grams per day of icosapent ethyl, have demonstrated a reduction in major cardiovascular events among specific high-risk populations.
To assess omega-3 levels accurately, testing can be beneficial. The omega-3 index, a blood test measuring EPA and DHA in red blood cells, is recognized as a reliable method for evaluating omega-3 status. Routhenstein explained that levels around 8% are associated with a lower risk of cardiovascular issues, while levels below 4% are considered low.
Individuals uncertain about their omega-3 status or the necessity for supplementation should consult a healthcare provider to develop an appropriate dietary strategy. As global health authorities emphasize the importance of omega-3s, understanding dietary intake and potential deficiencies could significantly impact health outcomes for millions.
